化学
阿布茨
区域选择性
抗氧化剂
抗菌活性
抗真菌
皮肤癣菌
药物化学
有机化学
立体化学
核化学
DPPH
催化作用
微生物学
细菌
生物
遗传学
作者
Natalia А. Elkina,Evgeny V. Shchegolkov,Yanina V. Burgart,Natalia A. Agafonova,Anastasia N. Perminova,Н. А. Герасимова,Галина Ф. Махаева,Елена Владимировна Рудакова,Надежда Владимировна Ковалева,Natalia P. Boltneva,Olga G. Serebryakova,Sophia S. Borisevich,Natalia P. Evstigneeva,Н. В. Зильберберг,Nikolay V. Kungurov,В. И. Салоутин
标识
DOI:10.1016/j.jfluchem.2021.109935
摘要
• Chemoselective synthesis of polyfluoroalkyl-4-arylhydrazinylidene-isoxazoles • Structural peculiarities of isoxazoles • Promising antimicrobial activity • Antioxidant activity is higher than Trolox one The regioselective cyclization of 2-arylhydrazinylidene-3-polyfluoroalkyl-3-oxo esters with hydroxylamine resulted in 4-arylhydrazinylidene-3-polyfluoroalkylisoxazol-5-ones, while the analogous reaction of 2-arylhydrazinylidene-3-polyfluoroalkyl-1,3-diketones led to 4-arylhydrazinylidene-5-polyfluoroalkyldihydroisoxazol-5-oles, which were dehydrated to 4-arylhydrazinylidene-5-polyfluoroalkylisoxazoles. To explain a regioselectivity of reactions, the quantum-chemical calculations were performed. The structure of the synthesized compounds was confirmed by IR, NMR spectroscopy, mass spectrometry, elemental analysis and X-Ray diffraction analysis. Almost all isoxazolones and dihydroisoxazoles demonstrated an inhibitory action against the majority of investigated strains of dermatophytes Trichophyton family, E. floccosum, and M. canis , while isoxazoles were found to be inactive. The lead compounds were 4-tolylhydrazinylidene-3-trifluoromethylisoxazol-5-one, 3-methyl-5-pentafluoroethyl- and 3-phenyl-5-trifluoromethyl-4-tolylhydrazinylidenedihydroisoxazol-5-oles having the antifungal activity against all dermatophyte strains (MIC 0.78…25 μg/kg) and C. ablicans yeasts (MIC 25 μg/kg). Seven derivatives showed a moderate antibacterial activity against N. gonorrhoeae (MIC 31.2…62.5 μg/kg). In addition, dihydroisoxazololes demonstrated a high antioxidant activity in the ABTS (TEAC is up to 2.0) and FRAP (TE is up to 1.91) tests, which could be helpful for hepatotoxicity reducing. The results obtained show the absence of anticholinesterase activity in all the compounds and demonstrate a weak inhibition of CES by most of the compounds, and that should be taken into consideration in the therapeutic use of the compounds in high doses.
科研通智能强力驱动
Strongly Powered by AbleSci AI